| BP category | Model 1 | Model 2 | ||||||
---|---|---|---|---|---|---|---|---|---|
 | E/N | HR | (95% CI) | p | HR | (95% CI) | P | ||
Total (N = 1232) | SBP < 120 | 61/367 | 0.92 | (0.63–1.34) | 0.67 | 0.94 | (0.64–1.38) | 0.75 | |
120 ≤ SBP < 130* | 49/224 | Ref |  |  | Ref |  |  | ||
130 ≤ SBP < 140 | 42/211 | 0.95 | (0.63–1.44) | 0.81 | 0.87 | (0.57–1.32) | 0.52 | ||
SBP ≥ 140 | 165/430 | 1.67 | (1.21–2.3) | 0.002 | 1.68 | (1.2–2.34) | 0.002 | ||
Treated (N = 286) | SBP < 120 | 10/36 | 1.32 | (0.5–3.5) | 0.57 | 1.39 | (0.51–3.8) | 0.52 | |
120 ≤ SBP < 130* | 7/27 | Ref |  |  | Ref |  |  | ||
130 ≤ SBP < 140 | 12/48 | 1.19 | (0.46–3.04) | 0.71 | 1.09 | (0.42–2.87) | 0.85 | ||
SBP ≥ 140 | 66/175 | 1.69 | (0.77–3.69) | 0.19 | 2.01 | (0.89–4.57) | 0.1 | ||
Untreated (N = 946) | SBP < 120 | 51/331 | 0.87 | (0.58–1.31) | 0.51 | 0.9 | (0.59–1.36) | 0.61 | |
120 ≤ SBP < 130* | 42/197 | Ref |  |  | Ref |  |  | ||
130 ≤ SBP < 140 | 30/163 | 0.85 | (0.53–1.36) | 0.5 | 0.8 | (0.5–1.29) | 0.37 | ||
SBP ≥ 140 | 99/255 | 1.62 | (1.12–2.34) | 0.01 | 1.64 | (1.13–2.39) | 0.009 | ||
Total (N = 1232) | DBP < 80 | 132/544 | 1.61 | (1.13–2.32) | 0.009 | 1.55 | (1.08–2.24) | 0.02 | |
80 ≤ DBP < 85* | 38/242 | Ref |  |  | Ref |  |  | ||
85 ≤ DBP < 90 | 45/165 | 1.88 | (1.22–2.90) | 0.004 | 1.93 | (1.25–2.98) | 0.003 | ||
DBP ≥ 90 | 102/281 | 2.68 | (1.85–3.89) | <0.001 | 2.63 | (1.8–3.83) | <0.001 | ||
Treated (N = 286) | DBP < 80 | 24/77 | 2.13 | (0.95–4.78) | 0.065 | 2.00 | (0.89–4.54) | 0.09 | |
80 ≤ DBP < 85* | 8/55 | Ref |  |  | Ref |  |  | ||
85 ≤ DBP < 90 | 11/38 | 2.1 | (0.84–5.22) | 0.11 | 1.96 | (0.77–4.95) | 0.16 | ||
DBP ≥ 90 | 52/116 | 4.02 | (1.9–4.85) | < 0.001 | 4.54 | (2.13–9.67) | <0.001 | ||
Untreated (N = 946) | DBP < 80 | 108/467 | 1.5 | (1.0–2.25) | 0.049 | 1.43 | (0.95–2.16) | 0.09 | |
80 ≤ DBP < 85* | 30/187 | Ref |  |  | Ref |  |  | ||
85 ≤ DBP < 90 | 34/127 | 1.84 | (1.13–3.01) | 0.015 | 1.94 | (1.19–3.18) | 0.008 | ||
DBP ≥ 90 | 50/165 | 2.09 | (1.33–3.29) | 0.001 | 1.95 | (1.23–3.08) | 0.004 | ||
Total (N = 1232) | PP < 40* | 46/327 | Ref |  |  | Ref |  |  | |
40 ≤ PP < 50 | 70/291 | 1.5 | (1.03–2.19) | 0.034 | 1.44 | (0.98–2.1) | 0.06 | ||
50 ≤ PP < 64 | 79/307 | 1.43 | (0.98–2.08) | 0.06 | 1.28 | (0.88–1.87) | 0.2 | ||
PP ≥ 64 | 122/307 | 2.13 | (1.48–3.06) | <0.001 | 1.92 | (1.33–2.78) | 0.001 | ||
Treated (N = 286) | PP < 40* | 12/37 | Ref |  |  | Ref |  |  | |
40 ≤ PP < 50 | 12/42 | 0.93 | (0.42–2.09) | 0.87 | 1.08 | (0.47–2.50) | 0.86 | ||
50 ≤ PP < 64 | 26/83 | 0.95 | (0.47–1.93) | 0.9 | 1.04 | (0.51–2.13) | 0.91 | ||
PP ≥ 64 | 45/124 | 1.06 | (0.55–2.06) | 0.86 | 1.16 | (0.59–2.27) | 0.66 | ||
Untreated (N = 946) | PP < 40* | 34/290 | Ref |  |  | Ref |  |  | |
40 ≤ PP < 50 | 58/249 | 1.67 | (1.09–2.57) | 0.019 | 1.52 | (0.98–2.36) | 0.058 | ||
50 ≤ PP < 64 | 53/224 | 1.5 | (0.96–2.34) | 0.075 | 1.31 | (0.84–2.06) | 0.24 | ||
PP ≥ 64 | 77/183 | 2.54 | (1.65–3.91) | <0.001 | 2.34 | (1.51–3.63) | < 0.001 |